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prevention programs and design of
educational programs for residents,
tourists, and healthcare workers.
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To the Editor: We were surprised
and disappointed by the brevity of
your article commemorating the 60th
anniversary of the establishment of
the Communicable Disease Center
(CDC) (1). We realize that the accom-
plishments of the center and its deriv-
ative agencies are vast and that to give
them full recognition would require
far more space in Emerging Infectious
Diseases than might be feasible.
Nevertheless, your article that appro-
priately identified Joe Mountin as the
administrative “father” of the center
omitted any mention of Alex
Langmuir, arguably the most influen-
tial of the infectious disease leaders
over the years. Langmuir’s creation
and direction of the Epidemic
Intelligence Service epitomized
CDC’s role in infectious diseases. His
legacy deserves recognition in any
chronicle of CDC, no matter how
short.
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In response: We thank Drs.
Winkelstein and Reingold for their
comment regarding our article on the
60 years of CDC’s progress in the area
of infectious diseases. We certainly
agree that Dr. Alexander Langmuir
has made enormous contributions to
this area, which we fully respect, We
further agree that a more comprehen-
sive approach would have required far
more space than allotted for these
types of commentaries. Allow us to
emphasize that the omission of Dr.
Langmuir and many other outstanding
colleagues was not an oversight but an
effort on our part to abbreviate an
exceptionally long list of these
deserving persons. We are looking
forward to opportunities to provide a
more comprehensive overview in
which many of them will be appropri-
ately recognized.
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